How many insider trades does FilingIQ track for VTAK?

FilingIQ tracks 24 Form 4 insider transactions for VTAK (Catheter Precision, Inc.), covering filings from Jan 16, 2024 onwards. 5 of those were filed in the last 90 days.

Are VTAK insiders net buyers or net sellers?

Across the full Form 4 history for VTAK, 6 transactions (25%) were open-market purchases and 1 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VTAK insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VTAK in?

Catheter Precision, Inc. (VTAK) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $2.96M.

VTAK insider trading

NYSE American Healthcare

Catheter Precision, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

25% / 4%

Market cap

$2.96M

About Catheter Precision, Inc.

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also offers LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. The company is based in Fort Mill, South Carolina.

Company website: www.catheterprecision.com

VTAK insider activity at a glance

FilingIQ has scored 24 insider transactions for VTAK since Jan 16, 2024. The most recent filing in our index is dated Mar 26, 2026.

Across the full history, 6 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VTAK insider trades is 66.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VTAK trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for VTAK?: FilingIQ tracks 24 Form 4 insider transactions for VTAK (Catheter Precision, Inc.), covering filings from Jan 16, 2024 onwards. 5 of those were filed in the last 90 days.
Are VTAK insiders net buyers or net sellers?: Across the full Form 4 history for VTAK, 6 transactions (25%) were open-market purchases and 1 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VTAK insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VTAK in?: Catheter Precision, Inc. (VTAK) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $2.96M.

Methodology & sources

Every VTAK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.